Merck Inc., announced that the company has received a Complete Response Letter from the FDA for the resubmission of the...
Cardiac Issues in Prostate Cancer management
Testosterone deficiency (TD) is an increasingly common problem with significant health implications, but its diagnosis and management can be challenging.
Apricus Biosciences, Inc. announced top-line results from the Phase IIb proof-of-concept study of fispemifene in men with secondary hypogonadism and...
CV Disease in Special Populations
Therapeutics MD, Inc. announced that the Company received a letter from the FDA stating that, as part of the FDA�s...
Palatin Technologies has announced positive, statistically significant top-line results from the Reconnect Studies, its Phase III clinical trial program of...
Impax Pharmaceuticals, a division of Impax Laboratories, Inc. has announced that the FDA has issued a Complete Response Letter regarding...
Forest Laboratories, Inc. and Gedeon Richter Plc. announced that the FDA has issued a Complete Response Letter regarding the New...
The FDA has issued new warnings concerning Avastin (bevacizumab) from Genentech/Roche, in relation to ovarian failure, osteo-necrosis of the jaw...